Reuters logo
BRIEF-EQL Pharma Q2 ‍EBITDA at SEK 0.1 mln
August 21, 2017 / 6:45 AM / 4 months ago

BRIEF-EQL Pharma Q2 ‍EBITDA at SEK 0.1 mln

Aug 21 (Reuters) - EQL PHARMA AB

* ‍CONSOLIDATED SALES FOR Q2 AMOUNTED TO SEK 6.7 (4.6) MILLION​

* ‍EBITDA FOR Q2 AMOUNTED TO SEK 0.1 (0.5) MILLION​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below